Cfms stock zacks

ConforMIS (CFMS) Reports Q4 Loss, Lags Revenue Estimates ...

ConforMIS Inc. - NASDAQ:CFMS - Stock Quote & News - TheStreet View detailed financial information, real-time news, videos, quotes and analysis on ConforMIS Inc. (NASDAQ:CFMS). Explore commentary on ConforMIS Inc. and hear what the experts at TheStreet are ConforMIS News | Markets Insider ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks 288d New Peer Reviewed Data Supports Use of Conformis Customized Knee … How to Pick Good Penny Stocks | Finance - Zacks

ConforMIS (CFMS) Stock Price History | wallmine

CFMS - Conformis Inc Stock quote - CNNMoney.com Find real-time CFMS - Conformis Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time CFMS - Conformis Inc stock quotes, company profile, news and forecasts from CFMS | Conformis Inc. Profile | MarketWatch Nov 05, 2019 · Conformis Inc. company facts, information and stock details by MarketWatch. View cfms business summary and other industry information. CFMS Conformis, Inc. Stock Quote - FINVIZ.com Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS) ACCESSWIRE Jul-31-19 07:55PM ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates Zacks -6.76% Conformis, Inc. Common Stock (CFMS) Earnings Report Date ...

ConforMIS (CFMS) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.16 per share a year ago.

Zacks Investment Research upgraded shares of ConforMIS (NASDAQ:CFMS) from a sell rating to a hold rating in a research report released on Tuesday, Zacks.com reports. The firm currently has $1.00 target price on the medical instruments supplier’s stock. According to Zacks, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement […] CFMS - Conformis CS News - Barchart.com

ConforMIS News | Markets Insider

Conformis, Inc. (CFMS), an orthopedic arthroplasty medical technology company, today announced proactive steps it is taking and planning to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic. “Our core product areas of knee and hip surgery are being Conformis, Inc. (CFMS) stock price, quote, history & news ...

Conformis, Inc. (CFMS) stock price, quote, history & news ...

ConforMIS (NASDAQ:CFMS) Upgraded by Zacks Investment ... Apr 04, 2020 · Zacks Investment Research upgraded shares of ConforMIS (NASDAQ:CFMS) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. Zacks Investment Research currently has $0.75 price target on the medical instruments supplier’s stock. According to Zacks, “ConforMIS, Inc. is a medical technology company which develops, manufacture …

2 Mar 2020 ConforMIS (CFMS) Reports Q4 Loss, Lags Revenue Estimates. Zacks Equity Research March 02, 2020. CFMS. Trades from $1.